Germany - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Germany Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry increased 4.4% year on year. In 2019, the country was ranked number 4 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry at $6,508,976,256.92 Million PPP. Germany is overtaken by Japan, which was ranked number 3 with $13,899,037,124.73 Million PPP and is followed by Switzerland with $5,040,677,150.71 Million PPP. United States ranked the highest with $70,565,318,932.39 Million PPP in 2019, that is a growth of 3.3% versus 2018. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania was the worst growing country at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 6,508,976,256.92 |
| 2018 | 6,337,105,359.33 |
| 2017 | 6,253,220,719.58 |
| 2016 | 6,002,386,271.06 |
| 2015 | 5,085,400,064.26 |
How does Germany rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data |
| 3 |
#3
Japan
|
13,899,037,124.73 | 2019 | +3.5 % | -0.9 % | View data |
| 4 |
#4
Germany
|
6,508,976,256.92 | 2019 | +2.7 % | +4.4 % | View data |
| 5 |
#5
Switzerland
|
5,040,677,150.71 | 2019 | +3.2 % | +3.8 % | View data |